Drug recall · August 19, 2020
Clobetasol Propionate Cream USP recall
Why: Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Clobetasol Propionate Cream USP, 0.05%, a) 15 g tube, NDC: 60429-902-15; b) 45 g tube, NDC: 60429-902-45, Rx Only, For External Use Only, Not for Ophthalmic Use, Mfd by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Marketed by: Golden State Medical Supply, Inc. Camarillo, CA 93012.
- Lots / codes
a) AB28353, Exp 12/31/2021; b) AB40178, Exp 12/31/2021
- Quantity
- 7632 tubes
- Company
- Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY
- Distribution
- Nationwide in the U.S.
- Initiated
- July 20, 2020 · Voluntary: Firm initiated
- Classified
- August 12, 2020
- Reported
- August 19, 2020
- Ended
- June 20, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clobetasol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.